WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will sponsor a dinner event during the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions at the Manchester Grand Hyatt in San Diego, California. Vascular robotics will be […]
Coronary/Structural Heart
Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
DUBLIN – April 5, 2018 – Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced Laura Mauri, M.D., M.Sc., interventional cardiologist and clinical researcher at the Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, will join Medtronic as Vice President, Global Clinical Research & […]
Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced that it, along with several other opponents, successfully opposed Edwards Lifesciences Corporation’s European patent EP 2,399,550 (‘550) in the European Patent Office (EPO), resulting in a revocation of the patent. The ‘550 patent was the only Edwards patent that […]
Ra Medical Systems Appoints Andrew Jackson as Chief Financial Officer
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr. Jackson has over 20 years of finance experience in life science and technology companies, including extensive […]
HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair
ZWICKAU, Germany, April 18, 2018 /PRNewswire/ — HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair. This approval will provide physicians the ability to remodel the leaflets of the mitral valve and reestablish proper coaptation. The CoAp Pro expands HeartStitch’s product line of cardiovascular […]
Emboline, Inc. Completes Funding Of Over $10 Million
SANTA CRUZ, Calif., April 19, 2018 /PRNewswire/ — Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures, announced today that it has completed a Series B funding round totaling over $10 million. The funding includes $3 million in new […]
Asahi Intecc To Begin Direct Sales Of Its Coronary Guide Wires
TUSTIN, Calif., April 12, 2018 /PRNewswire/ — Asahi Intecc USA, Inc. will begin direct sales of its coronary (PTCA) guide wires in the US. These guide wires are currently distributed by Abbott Vascular. As of July 1, 2018 the entire portfolio of Asahi PTCA guide wires will also be available directly from Asahi. All sales requests prior to July 1 should continue to be directed […]
CHF Solutions, Inc. Expands Operations into Hong Kong; Receives First Commercial Orders for Both Hong Kong and Singapore
EDEN PRAIRIE, Minn., April 12, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) announced today its commercial expansion into the Hong Kong market through its Asia distributor, Transmedic. Further, Transmedic has confirmed its first commercial orders for both Singapore and Hong Kong. “Our expansion into the Asian markets is a key […]
HeartStitch® Inc. has received CE Mark for Its Suture Based Trans-Apical Access and Closure
ZWICKAU, Germany, April 12, 2018 /PRNewswire/ — HeartStitch® Trans-Apical Access and Closure device provides safe and effective percutaneous trans-apical access for structural heart procedures and reliable closure. The proven suture-based technique emulates surgical closure without the need for open heart surgery or limited thoracotomy access (open surgical access to the heart between the ribs) when […]
Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease
ABBOTT PARK, Ill., April 11, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent implantation guided by high-resolution light-based imaging technology—called optical coherence tomography (OCT)—compared to a common X-ray-guided technique called angiography. The trial (ILUMIEN IV) is the first large-scale randomized global […]



